Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Richez

Showing results (31-40 of 206) with videos related to

Pageof 21
Sort By:
Joint Bone Spine|June 2, 2021
Practical management of patients on anti-IL17 therapy - the CRI guidelinesAnne Tournadre, Jérémie Sellam, Jacques Morel, et al.
Current Rheumatology Reports|July 19, 2017
New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus ErythematosusMarc Scherlinger, Vanja Sisirak, Christophe Richez, et al.
Autoimmunity Reviews|February 10, 2018
IgE in lupus pathogenesis: Friends or foes?Jean-François Augusto, Marie-Elise Truchetet, Nicolas Charles, et al.
Arthritis Research & Therapy|July 1, 2009
Myeloid dendritic cells correlate with clinical response whereas plasmacytoid dendritic cells impact autoantibody development in rheumatoid arthritis patients treated with infliximabChristophe Richez, Thierry Schaeverbeke, Chantal Dumoulin, et al.
Joint Bone Spine|March 7, 2019
Rare diseases that mimic Systemic Lupus Erythematosus (Lupus mimickers)François Chasset, Christophe Richez, Thierry Martin, et al.
Rheumatology (Oxford, England)|August 14, 2015
Immunogenicity of biologic agents in rheumatoid arthritis patients: lessons for clinical practiceThierry Schaeverbeke, Marie-Elise Truchetet, Marie Kostine, et al.
Lupus Science & Medicine|May 9, 2025
Anti-CD20 alone as maintenance immunosuppressive therapy in severe lupus nephritis: a promising experience that needs to be evaluatedSébastien Boutinet, Ludivine Lebourg, Stanislas Faguer, et al.
Rheumatology (Oxford, England)|September 3, 2020
Rapidly progressive interstitial lung disease under FOLFOX treatment for colorectal cancer associated with systemic sclerosis: two case reportsSamar El-Hout, Lea Lopez, Thierry Schaeverbeke, et al.
Lupus|September 30, 2022
Pilot study on accelerated aging in lupus using epigenetic biomarkers of ageNoémie Gensous, Patrick Blanco, Estibaliz Lazaro, et al.
Joint Bone Spine|November 28, 2021
Galectin 9, CXCL-10 and tumor necrosis factor receptor type II as biomarkers of disease activity in systemic lupus erythematosusNoémie Gensous, Damien Vagner, Thomas Barnetche, et al.
Pageof 21

Showing results (31-40 of 206) with videos related to

Sort By:
Pageof 21
Joint Bone Spine|June 2, 2021
Practical management of patients on anti-IL17 therapy - the CRI guidelinesAnne Tournadre, Jérémie Sellam, Jacques Morel, et al.
Current Rheumatology Reports|July 19, 2017
New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus ErythematosusMarc Scherlinger, Vanja Sisirak, Christophe Richez, et al.
Autoimmunity Reviews|February 10, 2018
IgE in lupus pathogenesis: Friends or foes?Jean-François Augusto, Marie-Elise Truchetet, Nicolas Charles, et al.
Arthritis Research & Therapy|July 1, 2009
Myeloid dendritic cells correlate with clinical response whereas plasmacytoid dendritic cells impact autoantibody development in rheumatoid arthritis patients treated with infliximabChristophe Richez, Thierry Schaeverbeke, Chantal Dumoulin, et al.
Joint Bone Spine|March 7, 2019
Rare diseases that mimic Systemic Lupus Erythematosus (Lupus mimickers)François Chasset, Christophe Richez, Thierry Martin, et al.
Rheumatology (Oxford, England)|August 14, 2015
Immunogenicity of biologic agents in rheumatoid arthritis patients: lessons for clinical practiceThierry Schaeverbeke, Marie-Elise Truchetet, Marie Kostine, et al.
Lupus Science & Medicine|May 9, 2025
Anti-CD20 alone as maintenance immunosuppressive therapy in severe lupus nephritis: a promising experience that needs to be evaluatedSébastien Boutinet, Ludivine Lebourg, Stanislas Faguer, et al.
Rheumatology (Oxford, England)|September 3, 2020
Rapidly progressive interstitial lung disease under FOLFOX treatment for colorectal cancer associated with systemic sclerosis: two case reportsSamar El-Hout, Lea Lopez, Thierry Schaeverbeke, et al.
Lupus|September 30, 2022
Pilot study on accelerated aging in lupus using epigenetic biomarkers of ageNoémie Gensous, Patrick Blanco, Estibaliz Lazaro, et al.
Joint Bone Spine|November 28, 2021
Galectin 9, CXCL-10 and tumor necrosis factor receptor type II as biomarkers of disease activity in systemic lupus erythematosusNoémie Gensous, Damien Vagner, Thomas Barnetche, et al.
Pageof 21